Eli Lilly and Co (LLY)
763.98
+6.28
(+0.83%)
USD |
NYSE |
May 14, 16:00
763.44
-0.54
(-0.07%)
Pre-Market: 20:00
Eli Lilly 1 Year Total Returns (Daily): 76.86% for May 14, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 14, 2024 | 76.86% |
| May 13, 2024 | 75.40% |
| May 10, 2024 | 75.79% |
| May 09, 2024 | 81.60% |
| May 08, 2024 | 80.58% |
| May 07, 2024 | 83.31% |
| May 06, 2024 | 80.70% |
| May 03, 2024 | 71.87% |
| May 02, 2024 | 88.56% |
| May 01, 2024 | 92.99% |
| April 30, 2024 | 98.95% |
| April 29, 2024 | 87.77% |
| April 26, 2024 | 96.56% |
| April 25, 2024 | 89.92% |
| April 24, 2024 | 92.58% |
| April 23, 2024 | 95.17% |
| April 22, 2024 | 91.41% |
| April 19, 2024 | 97.68% |
| April 18, 2024 | 103.3% |
| April 17, 2024 | 103.3% |
| April 16, 2024 | 100.9% |
| April 15, 2024 | 102.0% |
| April 12, 2024 | 105.4% |
| April 11, 2024 | 110.4% |
| April 10, 2024 | 109.3% |
| Date | Value |
|---|---|
| April 09, 2024 | 107.3% |
| April 08, 2024 | 112.8% |
| April 05, 2024 | 118.3% |
| April 04, 2024 | 118.4% |
| April 03, 2024 | 123.1% |
| April 02, 2024 | 124.3% |
| April 01, 2024 | 123.3% |
| March 28, 2024 | 132.3% |
| March 27, 2024 | 134.5% |
| March 26, 2024 | 132.4% |
| March 25, 2024 | 131.9% |
| March 22, 2024 | 134.8% |
| March 21, 2024 | 134.6% |
| March 20, 2024 | 133.6% |
| March 19, 2024 | 136.7% |
| March 18, 2024 | 133.6% |
| March 15, 2024 | 130.8% |
| March 14, 2024 | 134.5% |
| March 13, 2024 | 135.5% |
| March 12, 2024 | 141.6% |
| March 11, 2024 | 135.1% |
| March 08, 2024 | 145.9% |
| March 07, 2024 | 153.2% |
| March 06, 2024 | 146.5% |
| March 05, 2024 | 146.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-5.12%
Minimum
Oct 08 2019
153.2%
Maximum
Mar 07 2024
45.31%
Average
40.73%
Median
Aug 04 2020
1 Year Total Returns (Daily) Benchmarks
| Amgen Inc | 38.18% |
| Biogen Inc | -26.72% |
| Johnson & Johnson | -2.96% |
| Vertex Pharmaceuticals Inc | 23.37% |
| Viking Therapeutics Inc | 221.8% |